| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | FIMM | pan-cancer | AAC | -0.018 | 0.9 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.022 | 0.9 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.022 | 0.9 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.0041 | 0.9 |